Industrial Farmacéutica Cantabria opens a new subsidiary in China
Within the framework of its sustained, entrepreneurial, internationalisation process, Industrial Farmacéutica Cantabria (IFC) is set to arrive in China after...
IFC to promote and sponsor MIT programmes in biomedical innovation
Industrial Farmacéutica Cantabria and the Massachusetts Institute of Technology (MIT) have signed an agreement through which the laboratory will promote and sponsor...
New scientific endorsement for IFC®CAF, technology based on mollusk eggs rich in growth factors
A new article in the prestigious “American Journal of Drugs in Dermatology” highlights the efficacy of IFC®CAF technology, developed and...
IFC achieves a turnover of 126 million euros in 2016
Sales of IFC Group in 2016 topped 126 million euros, with over 20% growth on the previous year, highlighting the...
IFC opens a new subsidiary in Mexico to boost its international expansion
IFC – Industrial Farmacéutica Cantabria – takes on a new challenge with the opening of a subsidiary in Mexico as...
IFC with the “Solidarity Association with Children of the Moon”
The “Association de solidarité avec les enfants de la lune” (Solidarity Association with Children of the Moon) is a charitable...
Heliocare in China
This month, we see the launch of Heliocare on the Chinese market, following in the footsteps of Endocare several months...
IFC invests 20 Million Euros in a new Sustainable Production Centre
IFC Industrial Farmacéutica Cantabria shall create an ambitious R&D and sustainable production centre in the region to boost the international...
IFC Skincare Maroc, new headquarter in Africa
IFC has disembarked on the African continent with the intention of developing business in this growing market. The headquarters in...